Ouyang N - Search Results

1

MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis.

Ouyang N, Zhu C, Zhou D, Nie T, Go MF, Richards RJ, Rigas B. Ouyang N, et al. PLoS One. 2012;7(7):e41585. doi: 10.1371/journal.pone.0041585. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844504 Free PMC article.

2

NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts.

Ouyang N, Williams JL, Rigas B. Ouyang N, et al. Carcinogenesis. 2008 Sep;29(9):1794-8. doi: 10.1093/carcin/bgn127. Epub 2008 Jun 9. Carcinogenesis. 2008. PMID: 18544566 Free PMC article.

3

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.

Zhu C, Cheng KW, Ouyang N, Huang L, Sun Y, Constantinides P, Rigas B. Zhu C, et al. Among authors: ouyang n. Stem Cells. 2012 Oct;30(10):2065-75. doi: 10.1002/stem.1139. Stem Cells. 2012. PMID: 22653497 Free PMC article.

4

Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer.

Cheng KW, Mattheolabakis G, Wong CC, Ouyang N, Huang L, Constantinides PP, Rigas B. Cheng KW, et al. Among authors: ouyang n. Int J Oncol. 2012 Oct;41(4):1199-203. doi: 10.3892/ijo.2012.1577. Epub 2012 Jul 27. Int J Oncol. 2012. PMID: 22842609 Free PMC article.

5

The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies.

Zhou D, Papayannis I, Mackenzie GG, Alston N, Ouyang N, Huang L, Nie T, Wong CC, Rigas B. Zhou D, et al. Among authors: ouyang n. Carcinogenesis. 2013 Apr;34(4):943-51. doi: 10.1093/carcin/bgs394. Epub 2013 Jan 21. Carcinogenesis. 2013. PMID: 23338686 Free PMC article.

6

Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats.

Mattheolabakis G, Mackenzie GG, Huang L, Ouyang N, Cheng KW, Rigas B. Mattheolabakis G, et al. Among authors: ouyang n. Pharm Res. 2013 Jun;30(6):1471-82. doi: 10.1007/s11095-012-0953-8. Epub 2013 Mar 13. Pharm Res. 2013. PMID: 23483440 Free PMC article.

7

NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.

Williams JL, Ji P, Ouyang N, Liu X, Rigas B. Williams JL, et al. Among authors: ouyang n. Carcinogenesis. 2008 Feb;29(2):390-7. doi: 10.1093/carcin/bgm275. Epub 2008 Jan 3. Carcinogenesis. 2008. PMID: 18174252 Free PMC article.

8

The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats.

Huang L, Mackenzie G, Ouyang N, Sun Y, Xie G, Johnson F, Komninou D, Rigas B. Huang L, et al. Among authors: ouyang n. Br J Pharmacol. 2011 Apr;162(7):1521-33. doi: 10.1111/j.1476-5381.2010.01162.x. Br J Pharmacol. 2011. PMID: 21175575 Free PMC article.

9

The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.

Xie G, Nie T, Mackenzie GG, Sun Y, Huang L, Ouyang N, Alston N, Zhu C, Murray OT, Constantinides PP, Kopelovich L, Rigas B. Xie G, et al. Among authors: ouyang n. Br J Pharmacol. 2012 Apr;165(7):2152-66. doi: 10.1111/j.1476-5381.2011.01705.x. Br J Pharmacol. 2012. PMID: 21955327 Free PMC article.

10

NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.

Spiegel A, Hundley TR, Chen J, Gao J, Ouyang N, Liu X, Go MF, Tsioulias GJ, Kashfi K, Rigas B. Spiegel A, et al. Among authors: ouyang n. Biochem Pharmacol. 2005 Oct 1;70(7):993-1000. doi: 10.1016/j.bcp.2005.06.027. Biochem Pharmacol. 2005. PMID: 16105666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters